Fuse Medical Inc Quick Ratio (FZMD) starting from the second quarter 2023 to second quarter 2022, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Fuse Medical Inc   (FZMD)

Fuse Medical Inc 's Quick Ratio

FZMD's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2023, Quick Ratio fell to 0.02 below Fuse Medical Inc average.

Within Medical Equipment & Supplies industry 227 other companies have achieved higher Quick Ratio than Fuse Medical Inc in second quarter 2023. While Quick Ratio total ranking in the second quarter 2023 has deteriorated compared to the prior quarter from 4050 to 4912.

Explain Quick Ratio?
How much Cash & cash equivalents FZMD´s has?
What are FZMD´s Current Liabilities?




FZMD Quick Ratio (Jun 30 2023)
Q2
(Mar 31 2023)
Q1
(Dec 31 2022)
Q4
(Sep 30 2022)
Q3
(Jun 30 2022)
Q2
Y / Y Current Liabilities Change 7.95 % 15.67 % 23.09 % 32.92 % 36.42 %
Y / Y Cash & cash equivalent Change -58.05 % -59.62 % -73.27 % -71.34 % -55.49 %
Quick Ratio MRQ 0.02 0.02 0.01 0.04 0.05
FZMD's Total Ranking # 4912 # 4050 # 4965 # 4892 # 4491
Seq. Current Liabilities Change 6.89 % -7.77 % 8.19 % 1.22 % 14.53 %
Seq. Cash & cash equivalent Change 20.09 % 42.71 % -70.78 % -16.23 % 15.6 %



Quick Ratio second quarter 2023 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 228
Healthcare Sector # 1124
Overall Market # 4912


Quick Ratio Statistics
High Average Low
2.17 0.31 0
(Jun 30 2014)   (May 31 2013)




Financial Statements
Fuse Medical Inc 's Current Liabilities $ 12 Millions Visit FZMD's Balance sheet
Fuse Medical Inc 's Cash & cash equivalent $ 0 Millions Visit FZMD's Balance sheet
Source of FZMD's Sales Visit FZMD's Sales by Geography


Cumulative Fuse Medical Inc 's Quick Ratio

FZMD's Quick Ratio for the trailling 12 Months

FZMD Quick Ratio

(Jun 30 2023)
12 Months
(Mar 31 2023)
12 Months
(Dec 31 2022)
12 Months
(Sep 30 2022)
12 Months
(Jun 30 2022)
12 Months
Y / Y Current Liabilities TTM Growth 19.08 % 26.4 % 29.8 % 33.61 % 30.77 %
Y / Y Cash & cash equivalent TTM Growth -67.54 % -65.01 % -65.04 % -61.84 % -37.38 %
Quick Ratio TTM 0.02 0.03 0.04 0.05 0.09
Total Ranking TTM # 4293 # 3385 # 4286 # 3363 # 4274
Seq. Current Liabilities TTM Growth 1.93 % 3.44 % 5.44 % 7.11 % 8.2 %
Seq. Cash & cash equivalent TTM Growth -23.87 % -17.5 % -18.55 % -36.55 % -17.93 %


On the trailing twelve months basis Due to rise in Current Liabilities in the Q2 2023 to $12.06 millions, cumulative Quick Ratio decreased to 0.02 below the Fuse Medical Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 239 other companies have achieved higher Quick Ratio than Fuse Medical Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2023 from 3385 to 4293.

Explain Quick Ratio?
How much Cash & cash equivalents FZMD´s has?
What are FZMD´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 240
Healthcare Sector # 1127
Within the Market # 4293


trailing twelve months Quick Ratio Statistics
High Average Low
1.43 0.25 0.02
(Sep 30 2017)   (Jun 30 2023)




Companies with similar Quick Ratio in the quarter ending Jun 30 2023, within Medical Equipment & Supplies Industry Quick RatioJun 30 2023 MRQ Cash & cash equivalentJun 30 2023 MRQ Current Liabilities
Qhslab Inc   0.05 $ 0.109  Millions$ 2.065  Millions
Allurion Technologies Inc   0.05 $ 4.737  Millions$ 89.886  Millions
Dynatronics Corporation  0.05 $ 0.399  Millions$ 7.941  Millions
Ss Innovations International Inc  0.05 $ 0.423  Millions$ 8.789  Millions
Oceantech Acquisitions I Corp   0.04 $ 0.203  Millions$ 4.541  Millions
Biotricity Inc   0.04 $ 0.672  Millions$ 15.098  Millions
Blueriver Acquisition Corp  0.04 $ 0.106  Millions$ 2.391  Millions
Legacy Ventures International Inc  0.04 $ 0.002  Millions$ 0.039  Millions
The Pennant Group Inc   0.04 $ 2.838  Millions$ 68.477  Millions
Yubo International Biotech Limited  0.04 $ 0.118  Millions$ 2.949  Millions
Altitude Acquisition Corp   0.04 $ 0.081  Millions$ 2.314  Millions
Invo Fertility Inc   0.03 $ 0.112  Millions$ 4.469  Millions
Euda Health Holdings Limited  0.02 $ 0.189  Millions$ 8.717  Millions
Fuse Medical Inc   0.02 $ 0.253  Millions$ 12.064  Millions
Non Invasive Monitoring Systems Inc  0.02 $ 0.007  Millions$ 0.335  Millions
Envoy Medical Inc   0.02 $ 0.133  Millions$ 6.570  Millions
Holdco Nuvo Group D g Ltd   0.02 $ 0.553  Millions$ 30.945  Millions
Trisalus Life Sciences Inc   0.02 $ 0.104  Millions$ 6.032  Millions
Vycor Medical Inc   0.02 $ 0.059  Millions$ 3.779  Millions
Smith and Nephew Plc  0.01 $ 33.000  Millions$ 2,271.000  Millions
Yunhong Green Cti Ltd   0.01 $ 0.100  Millions$ 8.629  Millions
Sanuwave Health Inc   0.01 $ 0.332  Millions$ 28.809  Millions
Medicale Corp.  0.01 $ 0.000  Millions$ 0.018  Millions
Infusystem Holdings Inc  0.01 $ 0.134  Millions$ 12.867  Millions
Arch Therapeutics Inc   0.01 $ 0.087  Millions$ 9.579  Millions
Vystar Corporation  0.01 $ 0.050  Millions$ 5.999  Millions
Sigyn Therapeutics Inc   0.01 $ 0.024  Millions$ 3.246  Millions
Vsee Health Inc   0.01 $ 0.031  Millions$ 5.044  Millions
Marizyme Inc   0.01 $ 0.235  Millions$ 46.210  Millions
Nocturne Acquisition Corporation 0.00 $ 0.029  Millions$ 6.072  Millions

Date modified: 2026-09-08T15:11:02+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.